Cyclodextrin-mediated enhancement of riboflavin solubility and corneal permeability

Molecular Pharmaceutics

Volumn 10, Issue 2, 2013, Pages 756-762

  Morrison, Peter W J ^a   Connon, Che J ^a   Khutoryanskiy, Vitaliy V ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

cornea; corneal cross linking; corneal epithelium; cyclodextrin; Franz diffusion cell; ocular drug delivery; permeability; riboflavin; trans corneal

Indexed keywords

ALPHA CYCLODEXTRIN; BETA CYCLODEXTRIN; CYCLODEXTRIN; RIBOFLAVIN;

ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; CORNEA; CORNEA PERMEABILITY; DRUG DIFFUSION; DRUG EFFECT; DRUG FORMULATION; DRUG MECHANISM; DRUG PENETRATION; DRUG SOLUBILITY; IN VITRO STUDY; INTRAOCULAR DRUG ADMINISTRATION; KERATOCONUS; NONHUMAN; PRIORITY JOURNAL; STEADY STATE;

ANIMALS; CATTLE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORNEA; CYCLODEXTRINS; DRUG INTERACTIONS; PERMEABILITY; RIBOFLAVIN; SOLUBILITY;

EID: 84873392051     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp3005963     Document Type: Article

References (35)

1. Washington, N.; Washington, C.; Wilson, C. G. Ocular Drug Delivery. Physiological Pharmaceutics: Barriers to Drug Absorption, 2 nd ed.; CRC Press: Boca Raton, FL, 2001; pp 249-269.
2. Wilson, C. G.; Zhu, Y. P.; Kumala, P.; Rao, L. S.; Dhillon, B. Ophthalmic Drug Delivery. In Drug Delivery and Targeting for Pharmacists and Pharmaceutical Scientists; Hillery, A. M., Lloyd, A. W., Swarbrick, J., Eds.; CRS Press: Boca Raton, FL, 2001; pp 329-353.
3. Chandran, S.; Roy, A.; Saha, R. N. Effect of pH and Formulation Variables on in vitro Transcorneal Permeability of Flurbiprofen: a Technical Note AAPS PharmSciTech. 2008, 9, 1031-1037
4. Loch, C.; Zakelj, S.; Kristi, A.; Nagel, S.; Gutoff, R.; Weitschies, W. Determination of Permeability Coefficients of Ophthalmic Drugs Through Different Layers of Porcine, Rabbit and Bovine Eyes Eur. J. Pharm. Sci. 2012, 47, 131-138
5. Gautheron, P.; Dukik, M.; Alix, D.; Sina, J. Bovine Corneal Opacity and Permeability Test: An In Vitro Assay of Ocular Irritancy J. Appl. Toxicol. 1992, 18, 442-449
6. Tuft, S. J.; Moodaley, L. C.; Gregory, W. M.; Davison, C. R.; Buckley, R. J. Prognostic Factors for the Progression of Keratoconus Ophthalmology 1994, 101, 439-447 (Pubitemid 24100567)
7. Wollensak, G.; Spoerl, E.; Seiler, T. Riboflavin/Ultraviolet-A-induced Collagen Crosslinking for the Treatment of Keratoconus Am. J. Ophthalmol. 2003, 135, 620-627 (Pubitemid 36457967)
8. Roskams, J.; Rodgers, L. Lab Ref: A Handbook of Recipes, Reagents and Other Reference Tools for Use at the Bench; CSHL Press: New York, 2002; p 18.
9. Anyakora, C.; Afolami, I.; Ehianeta, T.; Onwumere, F. HPLC Analysis of Nicotinamide, Pyridoxine, Riboflavin and Thiamin in Some Selected Food Products in Nigeria Afr. J. Pharm. Pharmacol. 2008, 2, 029-036
10. Hoving, E. B. Chromatographic Methods in the Analysis of Cholesterol and Related Lipids J. Chromatogr., B 1995, 671, 341-362
11. Osman, H.; Yap, K. C. Comparative Sensitivities of Cholesterol Analysis Using GC, HPLC and Spectrophotometric Methods Malays. J. Anal. Sci. 2006, 10, 205-210
12. Challa, R.; Ahuja, A.; Ali, J.; Khar, R. K. Cyclodextrins in Drug Delivery: An Updated Review AAPS PharmSciTech. 2005, 6, 329-357
13. Cal, K.; Centkowska, K. Use of Cyclodextrins in Topical Formulations: Practical Aspects Eur. J. Pharm. BioPharm. 2008, 68, 467-478 (Pubitemid 351318207)
14. Chatjigakis, A. K.; Donze, C.; Coleman, A. W. Solubility Behaviour of β-cyclodextrin in Water/Cosolvent Mixtures Anal. Chem. 1992, 64, 1632-1634
15. Terekhova, I. V.; Tikhova, M. N.; Volkova, T. V.; Kumeev, R. S.; Perlovich, G. L. Inclusion Complex Formation of α- and β-cyclodextrins with Riboflavin and Alloxazine in Aqueous Solution: Thermodynamic Study J. Inclusion Phenom. Macrocyclic Chem. 2011, 69, 167-172
16. Higuchi, T.; Connors, K. A. Phase-solubility techniques Adv. Anal. Chem. Instrum. 1965, 4, 117-212
17. Liu, R.; Liu, Z.; Zhang, C.; Zhang, B. Gelucire44/14 as a Novel Absorption Enhancer for Drugs with Different Hydrophilicities: in Vitro and in Vivo Improvement on Transcorneal Permeation J. Pharm. Sci. 2011, 100, 3186-3195
18. Fujishama, H.; Toda, I.; Yamada, M.; Sato, N.; Tsubota, K. Corneal Temperature in Patients with Dry Eye Evaluated by Infrared Radiation Thermometry Br. J. Ophthalmol. 1996, 80, 29-32
19. Jarho, P.; Urtti, A.; Pate, D. W.; Suhonen, P.; Jarvinen, T. Increase in Aqueous Solubility, Stability and in vitro Permeability of anandamide by Hydroxypropyl-β-cyclodextrin Int. J. Pharm. 1996, 137, 209-216 (Pubitemid 26226072)
20. Grove, C.; Liebenberg, J. L.; Yang, W.; Villiers, M. M. Improving the Aqueous Solubility of Triclosan by Solubilisation, Complexation, and in Situ Salt Formation J. Cosmet. Sci. 2003, 54, 537-550 (Pubitemid 38253184)
21. Loftssona, T.; Jarvinen, T. Cyclodextrins in Ophthalmic Drug Delivery Adv. Drug Delivery Rev. 1999, 36, 59-79 (Pubitemid 29074477)
22. Sultana, Y.; Jain, R.; Aqil, M.; Ali, A. Review of Ocular Drug Delivery Curr. Drug Delivery 2006, 3, 207-217 (Pubitemid 43725018)
23. Roy, D. K.; Deb, N.; Ghosh, B. C.; Mukherjee, A. K. Inclusion of Riboflavin in β- cyclodextrin: A Fluorimetric and Absorption Spectrometric study Spectrochim. Acta, Part A 2009, 73, 201-204
24. Coffman, R. E.; Kildsig, D. O. Effect of Nicotinamide and Urea on the Solubility of Riboflavin in Various Solvents J. Pharm. Sci. 1996, 85, 951-954 (Pubitemid 26300222)
25. Zhunuspayev, D. E.; Mun, G. A.; Khutoryanskiy, V. V. Temperature- Responsive Properties and Drug Solubilization Capacity of Amphiphilic Copolymers Based on N-vinylpyrrolidone and Vinyl Propyl Ether Langmuir 2010, 26, 7590-7597
26. Jmol: An open-source Java viewer for chemical structures in 3D; http://www.jmol.org/.
27. Riboflavin. http://chemapps.stolaf.edu/jmol/jmol.php?model= O%3DC2%2FN%3DC%5C1%2FN%28c3cc%28c%28cc3%2FN%3DC%2F1C%28%3DO%29N2%29C%29C%29C%5B C%40H%5D%28O%29%5BC%40H%5D%28O%29%5BC%40H%5D%28O%29CO (accessed online: December 24, 2012).
28. Resch, M. D.; Resch, B. E.; Csizazia, E.; Imre, L.; Nemeth, J.; Revesz, P.; Csanyi, E. Permeability of Human Amniotic Membrane to Ofloxacin in Vitro Invest. Ophthalmol. Vis. Sci. 2010, 51, 1024-1027
29. Resch, M. D.; Resch, B. E.; Csizazia, E.; Imre, L.; Nemeth, J.; Revesz, P. S.; Csanyi, E. Drug Reservoir Function of Human Amniotic Membrane J. Ocul. Pharmacol. Ther. 2011, 27, 323-326
30. Ishino, Y.; Sano, Y.; Nakamura, T.; Connon, C. J.; Rigby, H.; Fullwood, N. J.; Kinoshita, S. Amniotic Membrane as a Carrier for Cultivated Human Corneal Endothelial Cell Transplantation Invest. Ophthalmol. Vis. Sci. 2004, 45, 800-806 (Pubitemid 38868373)
31. Azuaro-Blanco, A.; Pillai, C. T.; Dua, H. S. Amniotic Membrane Transplantation for Ocular Surface Reconstruction Br. J. Ophthalmol. 1999, 83, 399-402 (Pubitemid 29161178)
32. Fullwood, N. J.; Meek, K. M. An Ultrastructural, Time Resolved Study of Freezing in the Corneal Stroma J. Mol. Biol. 1994, 236, 749-758 (Pubitemid 24146320)
33. Yi-fei, H.; Meek, K. M.; Li-quang, W.; Da-jiang, W. Effect of freezing or drying on the swelling behavior of the bovine cornea Chin. Med. J. 2009, 122, 212-218
34. Zaidi, T.; Bajmoczi, M.; Zaidi, T.; Golan, D. E.; Pier, G. B. Disruption of CFTR- Dependant Lipid Rafts Reduces Bacterial Levels and Corneal Disease in a Murine Model of Pseudomonas aeruginosa Keratitis Invest. Ophthalmol. Vis. Sci. 2008, 49, 1000-1009
35. Ohtani, Y.; Irie, T.; Uekama, K.; Fukunaga, K.; Pitha, J. Differential Effects of α-, β- and γ- cyclodextrins on Human Erythrocytes Eur. J. Biochem. 1989, 186, 17-22 (Pubitemid 20015121)